title: Clinical trials: New drug for pancreatic cancer highlights the dual effect of regulatory approvals.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center, Herbert Irving Pavilion, 9th Floor, 161 Fort Washington Avenue, New York, New York 10032, USA; and the James J. Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, New York 10468, USA.
authors.forename: Susan E
authors.initials: SE
authors.lastname: Bates
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center, Herbert Irving Pavilion, 9th Floor, 161 Fort Washington Avenue, New York, New York 10032, USA; and the James J. Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, New York 10468, USA.
authors.forename: Tito
authors.initials: T
authors.lastname: Fojo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D021441:Carcinoma, Pancreatic Ductal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy*